Metal nanoparticles (MNPs) feature a metal core formed of inorganic metal or metal oxide that is usually surrounded by an organic or inorganic substance or metal oxide shell. Metal nanoparticles have a wide range of applications in day-to-day lives. The development of new economically viable ways of producing MNPs has resulted in pilot-scale production of MNPs, which have found a market in a variety of consumer products such as lotions, shampoos, apparel, footwear, and plastic containers. Metal oxide nanoparticles are increasingly being discovered by new antimicrobial specialists. These materials are expected to be produced and manipulated with various chemical functional groups, allowing them to be combined with antibodies, ligands, and pharmaceuticals of interest, opening up a wide range of possible uses in biotechnology, and magnetic separation. This is an excellent solution for safe microorganisms and expected to bring freedom to the metal oxide nanoparticle industry in the predicted year.
Market Scope and Structure Analysis
Description
The metal nanoparticles include platinum, gold, silver, iron, titanium, copper, and nickel. Silver nanoparticles have antibacterial activity against viruses, bacteria, and other eukaryotic microorganisms. Such factors result for its increasing popularity. The unique electrical, thermal, and optical capabilities of silver nanoparticles extend the applicability of photovoltaic to chemical sensing and biological applications. The expansion of the application scope of silver nanoparticles in the healthcare business is expected to drive up demand in the coming years.
COVID-19 Impact analysis
- The COVID-19 pandemic ceased the production of various products in the metal nanoparticles industry, which is attributed to the lockdown in countries worldwide. This has hampered the growth of metal nanoparticles market from the last few months and is likely to continue through 2022.
- COVID-19 affected the sales of metal nanoparticles in the first quarter of 2021 and is anticipated to have a negative impact on the market growth throughout the year.
- The major demand for metal nanoparticles was previously noticed in giant manufacturing countries, such as North America, Europe, Asia-Pacific, and South America, which are negatively affected by the spread of the coronavirus, thereby declining the demand for yarders.
- Further, potential impact of the lockdown is currently vague and financial recovery of companies is totally based on their cash reserves. Metal nanoparticles manufacturers can afford a full lockdown only for a few months, after which the players have to modify their investment plans. For instance, various players in the market halted their production activities for several weeks to reduce their expenses. On the contrary, few players adopted employee lay-offs to sustain themselves during the COVID-19 health crisis.
- Metal nanoparticles manufacturers are expected to focus on protecting their workforce, operations, and supply chains to respond to immediate crises and find new ways of working after COVID-19. For instance, provision of sanitizers, maintaining social distance, and ensuring the vaccination of every employee in the company can assist in promoting the health and safety of the workforce.
Top Impacting Factors
Metal nanoparticles are adopted in pharmaceutical, healthcare, and cosmetic sector. Due to their small size, metal nanoparticles may easily interact with biomolecules on the surface and inside cells, yielding superior signals and target specificity for diagnostics and treatments. This adds to its widespread use in image-guided in-vivo therapies and procedures for detecting organ & tissue changes and diagnosing chronic disorders. Furthermore, they are used as additives in food and restorative things, as well as brightening and anti-aging specialists in various remedial solutions. Hence, rise in demand for these nanoparticles in the medical care, personal care, and cosmetic care goods industries is expected to fuel metal nanoparticle market development throughout the forecast period.
- Increase in focus on healthcare and food & drug to reduce the risk of venous thromboembolism (VTE) propelled the market growth. For instance, in December 2021, the U.S. Food & Drug Administration has two pediatric indications for Xarelto also known as rivaroxaban. It is for treatment of venous thromboembolism (VTE) and the prevention of the risk of recurrent VTE in children aged birth to less than 18 years.
- Also, key players are adopting strategies such as acquisition and partnership to boost their drug test application. For instance, in August 2021, Bayer AG has acquired Vividion Therapeutics, Inc., which is a biopharmaceutical company in the U.S. The acquisition of Vividion strengthens Bayer's expertise in the field of small molecule drugs and extends the company's reach to new therapies.
- Similarly, in September 2021, UT Dallas and NovaCentrix collaborated on future solar panel production. They are expected to manufacture thin films with a technique called photonic curing. The thin films used in flexible electronics can be 1 million times faster than the traditional method. As a result, all such factors are anticipated to propel the metal nanoparticles market forward.
Key Benefits of the Report
- This study presents the analytical depiction of the metal nanoparticles industry along with the current trends and future estimations to determine the future investment pockets.
- The report presents detailed information related to key drivers, restraints, opportunities, and the metal nanoparticles market share.
- A quantitative analysis highlights the metal nanoparticles growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers and suppliers in the market.
- The report provides a detailed metal nanoparticles analysis based on competitive intensity and how the competition will take shape in coming years.
Metal Nanoparticles Market Report Highlights
| Aspects | Details |
 By Metal |
|
 By End-user Industry |
|
 By Region |
|
